US FDA approves Pfizer's RSV vaccine

The U.S. Food and Drug Administration on Wednesday approved Pfizer Inc's respiratory syncytial virus (RSV) vaccine for older adults, making it the second shot against the common respiratory disease that can be fatal for seniors.

Related Keywords

United States ,New York ,Bengaluru ,Karnataka ,India ,Americans ,Raghav Mahobe ,Astrazeneca Plc ,Moderna Inc ,Reuters ,Pfizer ,Drug Administration On ,Thomson Reuters Trust Principles ,Us Centers For Disease ,Pfizer Inc ,Drug Administration ,Disease Control ,Mariam Sunny ,Michael Erman ,Thomson Reuters Trust ,Rsbi Regulatory Oversight ,Rhpi Drug Device Trials ,Rhpi Regulatory ,Rhpi Government Health Policy ,Rhpi Public Health ,Mtpix ,Cmpny ,Covid ,Drudev ,Eu ,Gen ,Genhlt ,Hea ,Heca ,Humdis ,Infdis ,Intag ,Medreg ,Mrch ,Mrch1 ,Phag08 ,Phar ,Phar08 ,Phar1 ,Phmr ,Pol ,Prenew ,Pubhea ,Publ ,Pxp ,Regs ,Respir ,Vaccin ,Gb ,Weu ,Gamers ,Us ,Europ ,Namer ,Rhpi Approvals ,Bact ,Biz ,Cprod ,Govact ,Govadm ,Topnws ,Ef Business Future Of Health ,